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Highlights 
 Higher prenatal phthalate levels have been associated with offspring adverse 
neurodevelopment. 
 Molecular evidence can now be evaluated in human as well as animal studies.  
 In the absence of RCTs, alternative approaches are required for causal 
inference.  
 Epidemiological and molecular epigenetic analyses should be conducted in 
parallel.  
 A comprehensive set of approaches for causal and non-causal inference 
assessment.   
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Abstract 
Accumulating evidence, from animal models and human observational studies, 
implicates the in utero (and early postnatal) environment in the ‘programming’ of risk 
for a variety of adverse outcomes and health trajectories. The modern environment is 
replete with man-made compounds such as plastic product chemicals (PPC), 
including phenols and phthalates. Evidence from several human cohorts implicates 
exposure to these chemicals in adverse offspring neurodevelopment, though a direct 
causal relationship has not been firmly established. In this review we consider a 
potential causal pathway that encompasses epigenetic human variation, and how we 
might test this mechanistic hypothesis in human studies. In the first part of this report 
we outline how PPCs induce epigenetic change, focusing on the brain derived 
neurotrophic factor (BDNF) gene, a key regulator of neurodevelopment. Further, we 
discuss the role of the epigenetics of BDNF and other genes in neurodevelopment and 
the emerging human evidence of an association between phthalate exposure and 
adverse offspring neurodevelopment. We discuss aspects of epidemiological and 
molecular study design and analysis that could be employed to strengthen the level of 
human evidence to infer causality. We undertake this using an exemplar recent 
research example: maternal prenatal smoking, linked to methylation change at the aryl 
hydrocarbon receptor repressor (AHRR) gene at birth, now shown to mediate some of 
the effects of maternal smoking on birth weight. Characterizing the relationship 
between the modern environment and the human molecular pathways underpinning its 
impact on early development is paramount to understanding the public health 
significance of modern day chemical exposures.  
 
252 words 
Keywords 
Phthalate, bisphenol A, developmental origins, DNA methylation, neonatal 
epigenome, fetal programming, intrauterine environment, early birth cohort, causal 
evidence, observational epidemiology.  
 
 
1.1 Fetal programming and environmental exposures and an example of epigenetic 
mechanisms in linking the two 
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During pregnancy the developing fetus adapts to its environment to maximize survival. This 
is often referred to as ‘fetal programming’ and is usually associated with optimising growth 
while minimising the potential adverse effects of harmful exposures experienced in utero. 
Whilst beneficial in pregnancy, such adaptations can also be potentially deleterious to long-
term health. The Developmental Origins of Health and Disease (DOHaD) hypothesis states 
that the intrauterine environment can ‘program’ the fetus through subtle changes in organ 
structure or function, so as to predispose to disease in adulthood (Roseboom et al., 
2001),(Lewis et al., 2014). Accumulating evidence suggests a key role for epigenetic 
mechanisms (such as DNA methylation) in mediating this process (Waterland and Michels, 
2007). 
 
Several in utero environmental exposures have been linked to changes in neonatal epigenetic 
profile (reviewed extensively in Hogg et al.(Hogg et al., 2012)). Many of these findings were 
facilitated by the establishment and maintenance of large longitudinal birth cohorts that are 
now beginning to establish the case for epigenetic changes as the causal mediators of DOHaD 
mechanisms (Waterland and Michels, 2007). An exemplar is the reproducible association 
between maternal prenatal tobacco smoking and DNA methylation variation within the aryl 
hydrocarbon receptor repressor (AHRR) gene in offspring blood. An emerging fabric of 
evidence suggests that the association between maternal smoking, AHRR methylation and 
birthweight is indeed on the same causal pathway. Of particular note, recent work on the 
Avon Longitudinal Study of Parents and Children (ALSPAC) cohort has demonstrated that 
the association between maternal smoking and birth weight is in part mediated by AHRR 
methylation in cord blood, providing proof of principle for a more general epigenetic 
mediation model for the exposure-outcome relationship (Kupers et al., 2015).  Kupers et al 
recommend that the analytic strategy applied in the ALSPAC study may serve as a model that 
can extend to other exposures (Kupers et al., 2015). This is because the findings of such 
studies provide a higher level of causal evidence from observational studies in settings where 
randomised controlled trials are not possible.  
 
1.2 Plastic product chemicals as ubiquitous environmental exposures in pregnancy 
The potential impact of environmental man-made chemical exposure in early life is a 
significant public health concern, because even subtle chemical-induced changes during early 
development may increase subsequent risk of multiple diseases, particularly metabolic and 
neurodevelopmental disorders (Grandjean and Landrigan, 2006). Chemicals of concern 
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include the plastic product chemicals (PPC), such as phthalates, detectable in 96%-100% of 
pregnant women in modern populations (Centres for Disease Control and Prevention, 2015, 
Heffernan et al., 2013) and potentially associated with adverse neurodevelopmental outcomes 
in human observational studies(Factor-Litvak et al., 2014, Evans et al., 2014).  There is now 
extensive high quality animal and in vitro research, recently well reviewed (Lee et al., 2006, 
Ishido et al., 2004, Masuo et al., 2004b, Ishido et al., 2005). However, the degree to which 
these findings can be directly extrapolated to human populations is not known as it is highly 
likely that species specific differences exist in both the metabolism of phthalates and in 
neurodevelopmental processes. For example, for many brain regions, such as the 
hippocampus, postnatal rodent development equates to third trimester human development 
(Semple et al., 2013).  The peak in brain growth and gliogenesis occurs from 36-40 weeks in 
the human infant, but days 7-10 postnatally in the rodent (Semple et al., 2013).   
The US Centers for Disease Control and Prevention has stated that more research is needed to 
assess the human health effects of exposure to phthalates (Centres for Disease Control and 
Prevention, 2009). Hence, the purpose of this review is on the current level of human 
evidence and how causality may best be inferred using human studies which also incorporate 
molecular evidence.  
 
Humans now have near ubiquitous exposure to phthalate esters (phthalates) through food 
packaging, polyvinyl chloride (PVC) products and personal care products. Phthalates with 
lower molecular weight are common solvents in consumer products, e.g. in fragrance bases 
for household cleaning (Martina et al., 2012),(Rudel et al., 2011), cosmetics and personal care 
products (Dodson et al., 2012). In pregnant women, cosmetic use (Buckley et al., 2012) and 
baby products (Sathyanarayana et al., 2008) are each associated with elevated urinary 
metabolites of diethyl phthalate (DEP), dibutyl phthalate (DBP) and diethylhexyl phthalate 
(DEHP). Phthalates are the most common chemicals used as plasticizers, used to soften 
plastics such as PVC (National Industrial Chemicals Notification and Assessment Scheme, 
2008). The properties that impart usefulness as plasticisers also permit leaching, with the 
resultant potential for ongoing human exposure. Phthalates are readily absorbed through the 
oral route (National Industrial Chemicals Notification and Assessment Scheme, 2008) 
including via dust ingestion (Langer et al., 2014). However inhalation and trans-dermal 
absorption are also important, especially for lower molecular weight phthalates (National 
Industrial Chemicals Notification and Assessment Scheme, 2008). Placental transfer of 
phthalates and their metabolites is well established in animal models (Kang et al., 2006, 
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Fennell et al., 2004) and common phthalates and metabolites are detectable in human 
amniotic fluid, placenta, cord blood and breast milk (Osborne et al., 2011). Phthalates are 
recognised as endocrine disruptors with a wide range of actions and can have sex-specific 
effects (National Industrial Chemicals Notification and Assessment Scheme, 2008).  
 
1.3 Phthalate exposure and child neurodevelopmental outcomes 
The developing pregnancy undergoes the most rapid differentiation in the earliest stages and 
this is therefore likely to be a critical period of exposure. Of course, the developing infant 
also undergoes considerable postnatal brain development, so the window of any PPC-induced 
neurotoxic and vulnerability may not be confined to the prenatal period. For example, brain 
derived neurotrophic factor (BDNF) expression from gene promoters 1 and VI in the 
dorsolateral prefrontal cortex of humans occurs well beyond the fetal period; expression is 
seen during the first six years of life and declines thereafter (Wong et al., 2009).  
 
Neurodevelopmental disorders have become an increasingly prevalent problem for children 
in developed countries (Visser et al., 2014, Neggers, 2014, Hiscock et al., 2011, Grandjean 
and Landrigan, 2006, Grandjean and Landrigan, 2014). In the United States, the prevalence 
of both attention deficit hyperactivity disorder (ADHD)(Visser et al., 2014) and autism 
spectrum disorder (Neggers, 2014) has increased markedly over time. In Australia, 
neurobehavioral disorders account for 4 of the top 5 reasons for specialist paediatric 
attendance (Hiscock et al., 2011). Some, but not all, of this temporal increase may reflect 
diagnostic changes or better surveillance but this is unlikely to fully explain such a marked 
increase over time, nor parallel increases in more severe phenotypes. A potential increase in 
subclinical neurodevelopmental deficits is also of concern - indeed it has been proposed that 
neurodevelopmental disorders caused by industrial chemicals may have created a ‘silent 
pandemic’ in modern populations (Grandjean and Landrigan, 2006, Grandjean and 
Landrigan, 2014).  
 
Early life phthalate exposure is associated with behavioral effects in animal models (Masuo 
et al., 2004a), and neuroanatomical differences in synaptic density and organization (Smith et 
al., 2011).  In humans, early cross-sectional studies reported an association between current 
urinary phthalates and both ADHD (Kim et al., 2009) and decreased intelligence quotients in 
school children (Cho et al., 2010). To date, negative associations between increased exposure 
to phthalates in pregnancy and a broad range of early childhood neurodevelopmental 
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outcomes have been observed in the majority of cohorts that have reported on prenatal 
phthalate exposure and offspring cognition (Table 1). For example, in the Mount Sinai 
Children’s Environmental Health study, each natural log unit increase in low molecular 
weight phthalate exposure during pregnancy, was associated with a 2.4-fold increase in 
conduct problems (Engel et al., 2010), a 1.3-fold increase in attention problems (Engel et al., 
2010), and a 1.5-fold increase in social impairment(Miodovnik et al., 2011) at 4-9 years of 
age. The Columbia Center for Children’s Environmental Health study reported that among 
children of mothers with the highest versus lowest quartile of first trimester DnBP and DiBP 
levels , IQ was 6.7 (95% CI  1.9, 11.4) and 7.6 (95% CI   3.2, 12.1) points lower, respectively 
at age seven(Factor-Litvak et al., 2014). Overall, 8 of the 9 birth cohorts studied have found 
higher prenatal phthalate exposure to be associated with an adverse neurodevelopmental or 
behavior (Factor-Litvak et al., 2014, Whyatt et al., 2012, Engel et al., 2010, Gascon et al., 
2015, Kim et al., 2011, Miodovnik et al., 2011). The INMA Spanish birth cohort was the 
exception (Gascon et al., 2015) (Table1).  Sexual dimorphism is evident in some studies, 
consistent with the effect of phthalates on sex hormones (Sathyanarayana, 2008), which 
potentially influence epigenetic programming of the young brain (Weiss, 2012, Menger et al., 
2010).   
 
 
1.4 Plastic exposure and epigenetic variation at neurodevelopment genes - BDNF 
Emerging data, predominantly from animal studies, indicate that environmentally induced 
alterations to the vulnerable epigenome may have long-term consequences, particularly 
during the prenatal or early postnatal period. Several psychiatric and neurodevelopmental 
disorders have now been directly associated with epigenetic variation in physiologically 
relevant target genes, both in specific brain regions and the peripheral blood, predominantly 
from cross-sectional studies (Kundakovic et al., 2015). Studies in human peripheral blood 
indicate that epigenetic variation may exaggerate the adverse effect of gene variants for 
psychopathology (Kordi-Tamandani et al., 2012). 
 
Prenatal exposure to phthalates and bisphenols is linked to alterations in DNA methylation 
and gene expression in the blood of rodent offspring, modulated by underlying genetic profile 
(Singh and Li, 2012). Mounting evidence suggests that exposure to both phthalates and 
bisphenols may exert important epigenetic effects (Weiss, 2012).  By 2012, bisphenol and 
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phthalates had been related to widespread changes to methylation changes in over 20 human 
genes (Singh and Li, 2012).   
 
BDNF is a key neurodevelopmental gene, regulating synaptic plasticity, stimulation 
neurogenesis and synaptogenesis, and promoting cell survival in the central nervous system. 
A number of CpG islands (genomic regions enriched for potential sites of methylation) have 
been identified in promoters (p) p I, pII, p IV of the human BDNF gene. Case control studies 
have demonstrated epigenetic change in BDNF in peripheral blood among humans with 
schizophrenia (Kordi-Tamandani et al., 2012) or bipolar disease compared to those without 
other psychiatric conditions (Perroud et al., 2013),(Boulle et al., 2012).  
 
In animal models, prenatal intraperitoneal DBP administration (300mg/kg body weight) to 
mothers from day 6 in pregnancy to day 21 postnatal has been linked to BDNF epigenetic 
down-regulation in the brain of immature, but not mature, offspring suggesting a discrete 
developmental window of sensitivity (Li et al., 2014). Sexual dimorphism has also been 
observed (Li et al., 2014). For example, early postnatal (day 16 to 22) DEHP (10mg/kg) has 
associated with higher methylation of BDNF in the hippocampus with reduced gene 
expression and hippocampal atrophy in male not female rats (Smith et al., 2011). In mice, 
BPA induces greater DNA methylation in the transcriptionally relevant region of the BDNF 
gene in the hippocampus with an accompanying down regulation in gene expression. 
Moreover these changes are mirrored by BDNF methylation in matched peripheral blood of 
the mice (Kundakovic et al., 2014). This is important given the observed tissue specificity of 
many epigenetic marks, and has considerable implications for human studies where generally 
only peripheral tissues, rather than brain, are available for assessment of DNA methylation.   
 
2. Investigating causality between phthalate exposure and adverse neurodevelopment, 
mediated through epigenetic alteration of neurodevelopmental genes such as BDNF.  
Molecular evidence is available in animal models (Lee et al., 2006, Ishido et al., 2004, Masuo 
et al., 2004b, Ishido et al., 2005). This has been well reviewed recently (Miodovnik et al., 
2014, Holahan and Smith, 2015, Kay et al., 2014, Kay et al., 2013) and is not the purpose of 
this review.  In contrast, all human studies to date have been based on only epidemiological 
associations rather than molecular evidence (Table 1). Such associations could reflect non-
causal explanations. 
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Appropriately designed human longitudinal cohort studies are needed to allow the assessment 
of causal or non-causal inference in relation to PPC exposure in early life. In the era of big 
data, we now have many biological measures and accompanying statistical approaches 
available for assessing how likely findings are to be true positives or true negatives. A more 
comprehensive approach has long been used by epidemiologists to address concerns about 
bias and causality: for example, in investigations of possible components of hypothetical 
disease-causing pathways (Kuller et al., 2013, Ponsonby and Dwyer, 2014).  Hill’s criteria 
provide a strategy for inferring an association is more likely to be causal by assessing parallel 
features of causality (Hill, 1965),(Ponsonby and Dwyer, 2014). For the hypothesized causal 
pathway linking maternal prenatal smoking to low birth weight, with mediation by AHRR 
methylation status at birth to low birth weight (pathway, msmoke > mAHRR > lbw), many of 
these features are evident (discussed below). By applying similar criteria to a proposed causal 
pathway linking in utero phthalate exposure to adverse childhood cognition, mediated by 
BDNF methylation (pathway, pc > mBDNF > nd), we can begin to develop a more general 
framework to assist causal inference when studying the association between prenatal plastic 
chemical exposure, epigenetic variation in offspring and neurodevelopment in early life. 
Epidemiologic investigation using modern cohorts with deep neurodevelopmental 
phenotyping and serial biological and exposure measures offers a new opportunity to test 
causal and non-causal explanations of the current findings (Table 1). Ideally such studies 
would allow detailed epidemiologic investigation causal and non-causal features in the 
context of molecular biological evidence (Box) as discussed below. 
 
2.1 Cohort design and analysis and the assessment of causality 
 
2.1.1 High magnitude of association   
The association between smoking and low birth weight has been well established, with a 
(222g) birth weight reduction in offspring of smoking mothers in the ALSPAC cohort, a less 
than 10% reduction (Richmond et al., 2015). Although not markedly high (-8.1% (95% CI -
6.9%, -9.3%), the average AHRR methylation difference was the highest in magnitude of 15 
methylation variants associated with maternal smoking as assessed in cord blood for children 
in the same cohort (Richmond et al., 2015).  Major potential confounders such as maternal 
age were considered in the analysis (Richmond et al., 2015). The effect size between 
phthalates and neurodevelopmental outcomes is generally small to moderate and difficult to 
evaluate due to the different outcome measures used (Table 1).  Of concern is the finding in 
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the Columbia cohort that the highest vs. the lowest quartile of prenatal phthalates could be 
associated with an 8 point IQ reduction (Whyatt et al., 2012), although the estimates are 
imprecise. Overall, IQ is usually normally distributed with a mean of 100 and a standard 
deviation of 15 points. In any case even small effects would be of substantial public health 
significance given the highly prevalent exposures.  
 
2.1.2 Temporality –  
Exposure should precede outcome.  Prospective birth cohort studies allow this to be directly 
ascertained. In particular, access to maternal biological samples collected during pregnancy, 
ideally early, is crucial. 
2.1.3 Dose-response –  
AHRR methylation levels in offspring blood increase with antenatal smoking duration or 
intensity (Richmond et al., 2015).  For example, we previously found that only mothers who 
smoked throughout pregnancy, as opposed to those who quit once pregnancy was confirmed, 
showed evidence of a smoking-associated decrease in AHRR methylation in cord blood 
(Novakovic et al., 2014).  For phthalate exposure and adverse neurodevelopment, dose-
response trends have also been observed (Table 1). However, it is well known that with 
endocrine disrupting chemicals such as phthalates, non-monotonic responses may also occur 
(Andrade et al., 2006). 
2.1.4 Consistency and replication –  
For antenatal smoking and AHRR gene methylation, the association has now been 
demonstrated across studies (Factor-Litvak et al., 2014, Joubert et al., 2012, Novakovic et al., 
2014, Park et al., 2014, Shenker et al., 2013, Hogg et al., 2012). This consistency, with 
replication across cohorts, provides some reassurance against unmeasured confounding 
factors, such as population stratification, that may differ across different studies.   Further, the 
most recent work on the epigenetic mediation of maternal smoking has also been replicated 
(Kupers et al., 2015). For prenatal phthalates, the majority of cohorts have shown a positive 
association (Table 1). Birth cohorts have demonstrated adverse neurodevelopmental 
outcomes across a range of indices (Table 1).  
2.1.5 Coherence is consistency across different types of evidence.  Coherence is evident for 
the smoking, AHRR and low birth weight (Kupers et al., 2015), across multiple lines of 
evidence including in vitro and in vivo studies. In human studies, this evidence extends to 
replication of mediation pathways in part and also meta-analysis (Kupers et al., 2015).  For 
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phthalates, similar offspring behavioral problems have been demonstrated, for higher 
exposure in the prenatal period, for animals and humans (Miodovnik et al., 2014).  
Animal studies have also reported on phthalate-induced molecular change (Miodovnik et al., 
2014). Such studies are required to inform new human studies, particularly as phthalate 
interventions can be administered and target tissue, such as the hippocampus, examined. The 
opportunity now exists to assess molecular mechanisms in parallel in animal and human 
studies.  This will provide an improved evaluation of generalisability of animal studies to 
humans.  
And advance in neurotoxicology is the use of a neuroinfomative approach 
(http://www.translatingtime.net/)(Clancy et al., 2007).  This assists the problem of cross-
species comparisons as studies are related to various animal species (n=10) first and then to 
human brain development.  Improved translational technologies like this a required because 
of the paucity of human data.  For example, of 102 neurodevelopmental events, 15 have been 
studied in humans and 91 in rats (Clancy et al., 2007).  
 
2.1.6 Specificity –  
Given the advances in human molecular biology, specificity has become a more important 
attribute as genetic metabolism patterns can predict vulnerable populations. Other forms of 
specificity can also be evaluated. For the pathway msmoke > mAHRR > lbw, smoking-
associated methylation change in offspring cord blood was only apparent in maternal rather 
than paternal smoking with the authors stipulating the latter may have acted as a possible 
negative control (Davey Smith, 2013, Richmond et al., 2015). Further, the timing of exposure 
was consistent with prenatal exposure. Of the maternal smoking-related methylation variants, 
only some, not all, were associated with lower birth weight. This ruled out a potential 
spurious association between GF1 gene methylation variation and birth weight as reflecting 
better measurement of methylation than maternal smoking (Kupers et al., 2015).  
 
Specificity of genetic interplay is also likely to be important.  Both genetic and methylation 
variation exert regulatory control over gene expression.  Further, genotype can be expected to 
interact with methylation status, providing a differential impact for a given level of 
methylation on expression, depending on underlying genotype (Michels et al., 2013).  For 
AHRR methylation, this issue has not yet been fully examined, though we found some 
evidence for a genetic impact on the degree of AHRR methylation in cord blood of twins as 
part of our recent study of maternal smoking (Novakovic et al., 2014). With regard to 
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pathway pc>mBDNF>nd, overall, specificity is difficult to establish because multiple 
neurotoxicants, including tobacco smoke, lead (Grandjean and Landrigan, 2006) and 
bisphenol A (Mustieles et al., 2015) have been prospectively demonstrated to be associated 
with adverse child neurodevelopment.  Similarly, phthalates also have a broad range of 
offspring health outcomes, likely induced by endocrine disruption (Braun et al., 2013).  
In this setting, gene-environment interaction can provide further evidence of 
specificity. The dopamine receptor D4 (DRD4) 4/4 genotype is has been linked to attention 
deficit disorder (Park et al., 2014).   It has been shown that the adverse effects of phthalates 
on child cognitive tasks is more evident for children with the D4 4/4 genotype (Park et al., 
2014).  BDNF genotype has already been found to vary the strength of association between 
depression and methylation of a BDNF promoter in later life (Januar et al., 2015).  
Specifically, we reported three single nucleotide polymorphisms (rs6265, rs7103411 and 
rs908867) of the BDNF gene modify the association between depression and methylation 
(Januar et al., 2015).  A similar modification by gene variants of the association between 
BDNF methylation and offspring cognition would also be anticipated.  Parental specificity 
would occur if the link to methylation was stronger for maternal than paternal phthalate 
exposure (Davey Smith, 2013, Richmond et al., 2015).  This has not yet been examined for 
pathway pc>mBDNF>nd. 
2.1.7 Biological plausibility –  
In relation to the pathway msmoke > mAHRR > lbw, the Aryl hydrocarbon receptor mediates 
a variety of responses against environmental pollutants and thus might be anticipated to 
metabolize cigarette smoke. The AHRR pathway has been shown to mediate toxicity from 
other environmental pollutants such as polycyclic aromatic hydrocarbons (Timme-Laragy et 
al., 2007), dioxin (Mandavia, 2015) and naturally occurring mycotoxins such as aflatoxin 
B1(Goen et al., 2011). For the pathway pc > mBDNF > nd, animal studies have provided 
biological plausibility. Phthalates are associated with behavioral effects (Masuo et al., 
2004a), and neuroanatomical differences in synaptic density and organization (Smith et al., 
2011).  DBP has been linked to BDNF epigenetic down-regulation in immature, but not 
mature rats, indicating a discrete developmental window of sensitivity (Li et al., 2014).  
2.1.8 Analogy 
Richmond et al have indicated that, if the ALSPAC cohort had greater statistical power, the 
use of a genetic variant as an instrumental variable for maternal smoking with a one step 
Mendelian randomisation (MR) approach could have provided further evidence to increase 
the likelihood of causality (Richmond et al., 2015) .  Because phthalates reduce BDNF 
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expression in association with reduced hippocampal spine density in male rats (Smith and 
Holahan, 2014), an MR approach could potentially target BDNF gene variants associated 
with reduced BDNF expression as a way of employing a MR approach to assist causal 
inference. 
2.1.9 Experimental evidence by randomized controlled trials –  
Randomized controlled trials are not easily applied with regard to hazardous prenatal 
exposures, thus this feature cannot been ethically utilized to test pathway 
msmoke>mAHRR>lbw.  
Intervention to reduce plastic product chemicals has shown short-term success in at least one 
study to limit food packaging (Rudel et al., 2011), but long term intervention has not been 
assessed.  One randomized trial providing written instructions of phthalate and BPA 
avoidance found no reduction in urinary phthalate of BPA levels and food testing indicated 
the presence of DEHP within food ingredients (Sathyanarayana et al., 2013). The authors 
concluded that Federal or industry-wide regulation aimed at reducing phthalate and BPA 
concentrations in foods may be the only effective mechanism to ensure the food supply is 
safe from contamination (Sathyanarayana et al., 2013, Braun et al., 2013), highlighting the 
fact that phthalate avoidance RCTs will be problematic  
2.1.10 One step Mendelian randomisation (MR) 
 As discussed above, a genetic variable can act as an instrumental variable, creating a proxy 
for exposure, if the gene variant is robustly related to exposure. Further, these gene variants 
should not be influenced by the development of the disease.  These genetic variants are not 
likely to be related to confounders that explain non-genetic associations and are unaffected by 
disease (Smith et al., 2007). Thus, the demonstration of an association between such a gene 
variant, acting as an instrumental variable, can be used to strengthen causal inference.   
2.1.11 Two Step Mendelian randomisation.    
Relton and Davey Smith have highlighted that in utero exposures offer a unique opportunity 
to further utilize two step Mendelian randomisation. For the first step, a maternal gene variant 
as an instrumental variable for a maternal exposure and the association between this and the 
fetal gene methylation is examined (Relton and Davey Smith, 2012). The association between 
the maternal exposure and the methylation level of the offspring gene of interested can then 
be compared to the association between the instrumental variable- maternal genotype- by 
conventional regression and the fetal gene methylation by a test of endogeneity (Relton and 
Davey Smith, 2012).  If similar results are obtained, then one can infer that the conventional 
analysis is valid or that the instrumental variable analysis is not violated (Relton and Davey 
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Smith, 2012).  For the second step, offspring genotype, such as a cis genetic variant, can be 
used as a marker of fetal gene methylation and related to outcome. This two-step approach 
allows better discrimination that the maternal exposure is causally related to the offspring 
outcome through the methylation and reduces issues of measurement error and confounding. 
A recent example of the successful utilisation of this approach the confirmation of the effect 
of maternal red blood cell folate levels on methylation of the offspring MTHFR gene (Binder 
and Michels, 2013).  Nevertheless, problems remain for MR with regard to pleiotropy, 
linkage disequilibrium- (genetic confounding) and developmental compensation (Relton and 
Davey Smith, 2012). If the genotype is a weak proxy for the environmental factor or 
phenotype this can lead to low statistical power or bias (Burgess and Thompson, 2011).  
2.1.12 Mediation Analysis to explicitly explore causal mechanisms:   
Mediation analysis is a rapid and promising area of epidemiology. Mediation of an observed 
association between exposure and outcome by variability in a biomarker along the proposed 
causal pathway, explicitly evaluates the proposed causal mechanism alongside that observed 
association. For example, in the ALSPAC study, AHRR DNA methylation has been shown to 
mediate the association between maternal prenatal smoking on offspring low birth weight 
(Kupers et al., 2015). 19% of the 202g lower birthweight in exposed newborns could be 
explained by mediation through differential CPG methylation (Kupers et al., 2015).  This was 
assessed using the widely known Baron and Kenny approach (Baron and Kenny, 1986) and 
the Sobel test (Sobel, 1986).  Care should always be taken to not classify as mediator factors 
which are, in fact, consequences of exposure and outcome (Cole et al., 2010). In addition, it 
should be remember that the Baron and Kenny approach relies on the sequential ignorability 
assumption (Hicks RT, 2011); it assumes that there is no confounding in the relationship 
between the putative mediator and the outcome measure, and thus may overestimate the 
degree of mediation (Emsley et al., 2010).  Nonetheless, methodologic advances in causal 
mediation analysis (Imai, 2010, Buis, 2010, Richiardi et al., 2013, Valeri and Vanderweele, 
2013, Nguyen et al., 2015, Lepage et al., 2016) and molecular biology over the past five years  
have now made mediation analysis a strikingly more important component of compiling 
evidence on causality.    
 
 
3 Non-causal explanations 
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3.1 Reduction in measurement error  
Prenatal smoking and birthweight are factors that may be measured more precisely than 
prenatal plastics and adverse neurodevelopmental outcomes. In assessing the association 
between prenatal phthalate exposure and child neurodevelopment, care must be taken to 
reduce measurement errors of both exposure and outcome.  In the US Nurses’ Health Study, 
seven of eight phthalates and phthalate acid were relatively stable even over 1-3 years (ICC 
0.39-0.55)(Townsend et al., 2013). In relation to pregnancy, the reproducibility for some 
phthalates across trimester 2,3 and 3 months postpartum was even higher (Fisher et al., 2015). 
These include MEP (ICC 0.76 (95% CI 0.69, 0.83) and MBzP (ICC 0.73 (95% CI 
0.65,0.80)).  If these ICCs were too low in a setting where the exposure actually exerted low 
magnitude effects, the large non-differential misclassification could potentially obscure any 
positive association. Simulation findings indicate that an ICC of 0.42 in an exposure variable 
would result in the median relative risk reduction of 32% (de Klerk et al., 1989). The 
detection of positive associations between prenatal phthalates and adverse infant 
neurodevelopment in human cohorts is consistent with prenatal phthalates exerting relatively 
high magnitude effects which remain evident despite potential phthalate exposure 
misclassification due to the use of one spot urine. 
Nevertheless, it is likely that measurement error will not be eliminated, so repeated measures 
of prenatal phthalate exposure would be of further benefit, allowing within-person assessment 
of exposure variation and the calculation of a deattenuation factor to correct for measurement 
error (Preis et al., 2011).  Further, measurement error can be reduced by grouping the relevant 
metabolites and parent compounds in appropriate groups depending on the postulated 
mechanism of action. 
3.2 Bias minimisation and evaluation.   
Care should be taken to minimize participation and attrition bias in the cohort by achieving 
appropriate recruitment for the study with little loss to follow-up.  If the later does occur, an 
assessment of the impact of attrition can be conducted using inverse probability weighting 
(Dwyer et al., 2011, Little, 2002) . Measurement bias will be minimized by prospective 
exposure assessment and outcome assessment blind to the original exposure status of the 
child. Live birth cohort bias should be considered. If prenatal plastics act as a common cause 
of both fetal loss and adverse neurodevelopment, then plastics could even appear protective 
against adverse neurodevelopment in a live birth cohort; Danish birth cohort modelling 
 
 
15
reveals this is because excessive adverse neurodevelopment losses can occur amongst the 
fetal death group (Liew et al., 2015). Adjustment for common causes of fetal loss and adverse 
neurodevelopment would thus ideally is required. 
3.3 Confounder control:  
A comprehensive assessment of confounding is required.  The importance of these factors 
can be assessed by 2 by 2 contingency tables and change in estimate methods (Greenland, 
1989).  The effect of a putative factor on the magnitude of the exposure when included as a 
covariate in multivariable models can be determined.  More complex models, such as 
marginal structural models to account for time-varying confounders by inverse probability 
weighting (Karim et al., 2014) or G estimation (International Multiple Sclerosis Genetics et 
al., 2011) may be required. A wide causal framework should be considered.  In ALSPAC, 
offspring smoking at age 17, a possible marker of an inherited preference to smoke, was 
measured to allow adjustment for postnatal offspring smoking, although the potential 
confounding contribution of adolescent smoking was not able to be ruled out (Richmond et 
al., 2015).   
3.4   Assessment of reverse causation  
In the ALSPAC cohort a detailed examination of first trimester was undertaken to rule out 
any theoretical reverse causation whereby a mother with a larger fetus would change smoking 
habits before birth (Richmond et al., 2015). Serial measures of maternal smoking were 
examined to allow an estimation of the timing of the effect (Richmond et al., 2015).  Similar 
approaches using serial phthalate measures could be employed to obtain a careful evaluation 
of the temporality of the effect of phthalates and offspring neurodevelopment.  Further 
strategies can be conducted.  Restricted analyses can be conducted excluding the subset of 
outcomes thought to be particularly prone to reverse causation and the resulting change in 
magnitude of associations evaluated.  Backward and forward lagged analyses and the use of 
directed acyclic graphs to setup mediation analyses to evaluate the proportion of the 
association accounted for by the reverse pathway should be considered (Simpson Jr S et al., 
2014).  A new advance has been the use of bidirectional Mendelian randomisation to 
elucidate the causal direction between exposure and outcome, using valid genetic 
instrumental variables for each (Richmond et al., 2016). In this report, multiple causal 
inference strategies were used.  Their approach highlights the improvement in causal 
evidence quality when human molecular studies are incorporated in human studies. 
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In conclusion, we have highlighted the potential public health importance of observed 
associations between prenatal exposure to phthalates and suboptimal offspring 
neurodevelopment. The evidence is not conclusive and RCTs in this setting will be difficult 
to conduct well.  In the absence of RCTs, alternative approaches are needed. We have 
highlighted the value of conducting epidemiological and molecular epigenetic analyses in 
parallel with a view to assessing if detected phthalate- offspring adverse neurodevelopment is 
indeed mediated through altered methylation of key neurodevelopmental genes. Ideally 
human cohorts will utilize additional design features and analysis strategies to increase the 
likelihood that a detected association is causal, or identify non-causal explanations.  
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Table 1.  Cohort study reports on the prospective association between prenatal 
phthalate exposure and offspring cognition and developmental indices.   
 
 
Cohort  Prenatal 
Phthalate 
Exposure 
Neurodevelopmental Outcomes 
Male Children Female Children 
Mt Sinai CEH 
1998-2001, 
NY, US 
(n= ଵଷ଻,ଶଽହସ଴ସ  ) 
1st & 3rd 
trimester 
DMP DEP 
DBPs 
DEHP 
BBP DCPP 
NBAS at 5 days (Engel et al., 2009) 
 Orientation 
 Alertness 
 7 other domains & 
supplementary items 
BASC at 5-9y (Engel et al., 2010) 
 Externalizing (LMWP only) 
 Social skills (LMWP only)  
 Adaptability (all) 
 Internalizing  
NBAS at 5 days(Engel et al., 
2009) 
 Orientation Alertness 
(DEHP/HMWP only) 
 7 other domains & 
supplementary items  
BASC at 5-9y (Engel et al., 2010) 
 Externalizing  
 Social skills  
 Adaptability  
 Internalizing  
BRIEF at 5-9y (Engel et al., 2010) 
 GEC (LMWP only) 
SRS at 7-9y(Miodovnik et al., 2011) 
 Total SRS (LMWP only) 
Taiwan 
Maternal and 
Infant Cohort 
Study 
2000-2001 
(n=ଵଶଶସଷ଴) 
3rd 
trimester 
DMP DEP 
DnBP 
DEHP 
BBP 
WISC-III at 8-9y  
 (not reported) 
CBCL at 8-9y (Lien et al., 2015) 
 Externalizing (DEHP**, DnBP) 
 Social Problems(DEHP, trend DnBP) 
 Internalizing  
ELEMENT 
cohorts 2&3 
1997-2005, 
Mexico 
(n=ଵଷହଵ଻଴) 
3rd 
trimester 
DEP DBPs 
DEHP 
BBP DCPP 
BSID-II at 24 months(Tellez-Rojo 
et al., 2013) 
 MDI  
 PDI (BBP & DCPP only) 
 
BSID-II at 24 months(Tellez-Rojo 
et al., 2013) 
 MDI (DEHP only)** 
 PDI  
 
SFFII 
1999-2005, 
US 
(n=ଵସଵ,ଵହଷଽ଺ଵ ) 
 
10-39 
weeks 
DEP DBPs 
DEHP 
BBP 
Preschool Activity Inventory 3-
6y(Swan et al., 2010) 
 Masculine (DEHP**, trend 
DBPs)  Feminine play 
CBCL 6-10y(Kobrosly et al., 2014) 
 Internalizing (DEHP only)  
 Externalizing (DBPs, trend 
BBP) 
Preschool Activity Inventory 3-
6y(Swan et al., 2010) 
 Masculine play 
  Feminine play 
CBCL 6-10y(Kobrosly et al., 
2014) 
 Internalizing (BBP, trend 
DEHP)  
  Externalizing 
CCCEH 
1998-2006 
NY, US 
(n=ଶ଻଻,ଷଶ଼଻ଶ଻ ) 
3rd 
trimester 
DEP DBPs 
DEHP 
BBP  
BSID-II at 27-42 months (Whyatt et 
al., 2012) 
 MDI 
 PDI (DBPs only) 
CBCL at 33-48 months (Whyatt et 
al., 2012) 
 Internalizing (DBPs only)** 
 Externalizing 
BSID-II at 27-42 months (Whyatt 
et al., 2012) 
 MDI (DBPs only)** 
 PDI (DBPs only) 
CBCL at 33-48 months (Whyatt et 
al., 2012) 
 Internalizing(BBP, trend 
DBPs) 
 Externalizing 
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**= p=< 0.01 
n=௫,௬௭  where x = no. of children in 1
st group, y= no. of children in 2nd group and z = total 
sample  Positive or negative adverse associations generally p<0.05, **p <0.01 
 
 
 
  
WISC-IV at 7y (Factor-Litvak et al., 2014) 
 Full Scale IQ (DBPs**, trend BBP) 
HOME 
2003-2006 
Ohio, US 
(n=ଵ଻ହ,ଷସସଷ଼ଽ ) 
16 & 26 
weeks 
DEP DBPs 
DEHP 
BBP DCPP 
NNNS at 5 weeks(Yolton et al., 
2011) 
Arousal Handling 
requirements Regulation 
Movement quality (26 week 
DBPs only) 
 Nonoptimal reflexes 
 6 other dimensions of 
neurobehavior 
NNNS at 5 weeks(Yolton et al., 
2011) 
Arousal Handling 
requirements Regulation 
Movement quality (26 week 
DBPs only) 
 Nonoptimal reflexes (DEHP 
only) 
 6 other dimensions of 
neurobehavior 
 BASC at 2-3y (not reported as yet) 
BRIEF at 3y (not reported as yet) 
SRS at 4-5y  
INMA 
2004-2006 
Sabadell, 
Spain 
(n=ଷଷ଺,ଷ଺଻଺ହ଻ ) 
 
12 & 32 
weeks 
DEP DBPs 
DEHP 
BBP 
BSID at 12-18 months  (Gascon et al., 2015) 
McCarthy Scales  
California Preschool Social Competence Scale at 4 y 
 CP-SCS (DEHP, trend DEP) 
ADHD-DSM at 4y  
SDQ at 7y  
Conner’s Rating Scale at 7y 
 ADHD Index (DEHP only) 
MOCEH 
2005-2008 
Korea 
(n=ଵଶ଻,ସଵ଻ଵସଷହ ) 
3rd 
trimester  
DnBP 
DEHP 
BSID-II at 6 months (Kim et al., 
2011) 
 MDI (DnBP & DEHP) 
 PDI (DnBP & DEHP**) 
BSID-II at 6 months(Kim et al., 
2011) 
 MDI  
 PDI 
REPRO_PL 
2007-2011 
Poland 
(n= ଵହ଴ଵ଺ସ଻) 
3rd 
trimester 
DEP DBPs 
DEHP 
BBP DnOP 
DiNP 
Bayley-III at 24 months(Polanska et al., 2014) 
 Cognitive  
 Language 
 Motor  (DEHP/HMWP & DBPs) 
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Box. Cohort design and analysis features to be considered detecting and evaluating the 
prospective association between prenatal plasticisers and adverse neurodevelopment.  
These features assist causal and non-causal inference. 
 
 
 
 
Considerations / approaches for evaluation of causality 
 
 Magnitude of association (effect size)  
 Temporality 
 Consistency and replication  
 Coherence  
 Specificity  
 Biological plausibility  
 Analogy 
 Experimental evidence by RCT 
 One step Mendelian randomisation 
 Two Step Mendelian randomisation.  
 Mediation Analysis to explore causal mechanisms 
 
Evaluation of non-causality 
   
 Reduction in measurement error  
 Bias minimization and evaluation.   
 Confounder control 
 Assessment of reverse causation  
 
 
 
